Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase: A Multi-Center Randomized Placebo-controlled Trial

PURPOSE: To determine, in a multicenter double-blinded placebo-controlled trial, whether maximal hepatic arterial phase breath-holding duration is affected by gadoxetate disodium administration. MATERIALS AND METHODS: Institutional review board approval was obtained for this prospective multi-instit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiology
Main Authors: McClellan, Taylor R., Motosugi, Utaroh, Middleton, Michael S., Allen, Brian C., Jaffe, Tracy A., Miller, Chad M., Reeder, Scott B., Sirlin, Claude B., Bashir, Mustafa R.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5537625/
https://ncbi.nlm.nih.gov/pubmed/27509544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1148/radiol.2016160482
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados